市場調査レポート

商品コード

1653929

抗菌薬感受性試験市場規模、シェア、成長分析：製品別、タイプ別、方法別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Antimicrobial Susceptibility Testing Market Size, Share, and Growth Analysis, By Product, By Type, By Method, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年02月08日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,359円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 892,986円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,613円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.03円

全表示
概要
目次

概要

サンプル依頼リストに入れる

抗菌薬感受性試験市場規模は2023年に44億米ドルと評価され、2024年の46億3,000万米ドルから2032年には69億4,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.2％で成長する見通しです。

抗菌薬感受性試験（AST）市場は、ヘルスケア産業、特に感染症や微生物学の管理に不可欠な要素です。抗生物質耐性菌の急増や感染症の世界の増加に牽引され、信頼性の高い診断技術への需要が高まっています。自動化や高度な分子生物学的手法などの革新は、ASTの精度と効率を高める。しかし、AST技術の高コスト、標準化の欠如、複雑な手順といった課題が、特に中低所得地域における市場成長の妨げになる可能性があります。こうした障害にもかかわらず、市場には、特にポイント・オブ・ケア検査への動向や再生医療の進歩といった機会が与えられています。米国のAST市場は今後1年間、持続的な成長が見込まれます。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Thermo Fisher Scientific Inc.（US）
Bio-Rad Laboratories, Inc.（US）
Danaher Corporation（US）
Becton, Dickinson and Company（US）
bioMerieux SA（France）
Roche Diagnostics（Switzerland）
Abbott Laboratories（US）
Bruker Corporation（US）
Merck KGaA（Germany）
Agilent Technologies, Inc.（US）
ConvaTec Group plc（UK）
HiMedia Laboratories Pvt. Ltd.（India）
Liofilchem s.r.l.（Italy）
Accelerate Diagnostics, Inc.（US）
Creative Diagnostics（US）
Bio-Rad Laboratories（US）
Synbiosis（UK）
QIAGEN N.V.（Germany）

結論と提言

Product Code: SQMIG35B2120

Antimicrobial Susceptibility Testing Market size was valued at USD 4.4 billion in 2023 and is poised to grow from USD 4.63 billion in 2024 to USD 6.94 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The antimicrobial susceptibility testing (AST) market is a vital component of the healthcare industry, especially in managing infectious diseases and microbiology. Driven by the surge in antibiotic-resistant bacteria and the global rise in infectious diseases, there is an increasing demand for reliable diagnostic technologies. Innovations such as automation and advanced molecular methods enhance the accuracy and efficiency of AST. However, challenges such as the high cost of AST technologies, a lack of standardization, and complex procedures may hinder market growth, particularly in middle and low-income regions. Despite these obstacles, the market is presented with opportunities, particularly with the trend towards point-of-care testing and advancements in regenerative medicine. The US AST market is expected to experience sustainable growth in the coming forecast year.

Top-down and bottom-up approaches were used to estimate and validate the size of the Antimicrobial Susceptibility Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Antimicrobial Susceptibility Testing Market Segments Analysis

Global Antimicrobial Susceptibility Testing Market is segmented by Product, Type, Method, Application, End User and region. Based on Product, the market is segmented into Consumables, Lab Instruments and Lab Disposables. Based on Type, the market is segmented into Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing and Antiviral Susceptibility Testing. Based on Method, the market is segmented into Qualitative Methods and Quantitative Methods. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Epidemiology and Other Applications. Based on End User, the market is segmented into Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Clinical Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Antimicrobial Susceptibility Testing Market

The rise of Antimicrobial Resistance (AMR) poses a significant challenge to global health, prompting health organizations and authorities to emphasize the importance of effective Antimicrobial Susceptibility Testing (AST) to monitor resistance patterns. This testing plays a crucial role in informing treatment choices and promoting the appropriate use of antibiotics. Additionally, the increasing prevalence of infectious diseases, exacerbated by factors such as travel, urbanization, and population growth, necessitates timely diagnosis and treatment. Consequently, this surge in infectious cases fuels the demand for reliable and efficient AST, making it an essential component in the fight against AMR.

Restraints in the Antimicrobial Susceptibility Testing Market

The Antimicrobial Susceptibility Testing (AST) market faces several challenges, particularly in middle and low-income countries where there is a significant lack of awareness regarding the advantages of AST. This gap in understanding can hinder its widespread acceptance. Additionally, inadequate training of laboratory personnel on current testing methodologies further impedes the effective implementation of AST. Compounding these issues, the regulatory landscape governing diagnostic tools and solutions can be complex and time-consuming, with stringent requirements potentially delaying the launch of innovative AST technologies. Consequently, these factors may restrict the growth and accessibility of AST in certain regions.

Market Trends of the Antimicrobial Susceptibility Testing Market

The Antimicrobial Susceptibility Testing market is witnessing a significant trend toward the adoption of rapid testing techniques that deliver immediate results, transforming the landscape of pathogen detection and treatment decisions. Innovations such as mass spectrometry, molecular diagnostics, and automated systems are being rapidly developed to streamline the testing process, reducing turnaround times from days to mere hours. This shift is particularly impactful in critical care environments, where timely identification of bacterial resistance is vital for improving patient outcomes. As healthcare providers increasingly prioritize speed and accuracy in antimicrobial stewardship, the demand for rapid testing solutions is anticipated to surge, reshaping market dynamics.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis
Patent Analysis

Global Antimicrobial Susceptibility Testing Market Size by Product & CAGR (2025-2032)

Market Overview
Consumables
- Culture & Growth Media
- Susceptibility Testing Disks
- Mic Strips
- Susceptibility Testing Plates
Lab Instruments
- Automated Laboratory Instruments
- Molecular Diagnostics Systems
Lab Disposables

Global Antimicrobial Susceptibility Testing Market Size by Type & CAGR (2025-2032)

Market Overview
Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Antiviral Susceptibility Testing

Global Antimicrobial Susceptibility Testing Market Size by Method & CAGR (2025-2032)

Market Overview
Qualitative Methods
- Automated Ast
- Disk Diffusion
- Agar Dilution
- Genotypic Method
Quantitative Methods
- ETEST Method
- Broth Macrodilution

Global Antimicrobial Susceptibility Testing Market Size by Application & CAGR (2025-2032)

Market Overview
Clinical Diagnostics
Drug Discovery & Development
Epidemiology
Other Applications

Global Antimicrobial Susceptibility Testing Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals & Diagnostic Centers
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Clinical Research Organizations

Global Antimicrobial Susceptibility Testing Market Size & CAGR (2025-2032)

North America (Product, Type, Method, Application, End User)
- US
- Canada
Europe (Product, Type, Method, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Type, Method, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Type, Method, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Type, Method, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ConvaTec Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HiMedia Laboratories Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Liofilchem s.r.l. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accelerate Diagnostics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synbiosis (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

抗菌薬感受性試験市場規模、シェア、成長分析：製品別、タイプ別、方法別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Antimicrobial Susceptibility Testing Market Size, Share, and Growth Analysis, By Product, By Type, By Method, By Application, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

抗菌薬感受性試験市場規模：製品別& CAGR（2025-2032）

抗菌薬感受性試験市場規模：タイプ別& CAGR（2025-2032）

抗菌薬感受性試験市場規模：方法別& CAGR（2025-2032）

抗菌薬感受性試験市場規模：用途別& CAGR（2025-2032）

抗菌薬感受性試験市場規模：エンドユーザー別& CAGR（2025-2032）

抗菌薬感受性試験市場規模：地域別& CAGR（2025-2032）